ArticleJournal of liver cancer2025

Durable complete response after discontinuation of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma with portal vein tumor thrombosis: the first report.

Pramod Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.